Editas Medicine, Inc.
EDIT
$2.22
-$0.13-5.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -48.37% | -58.64% | 150.95% | 247.03% | 204.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -48.37% | -58.64% | 150.95% | 247.03% | 204.54% |
| Cost of Revenue | -14.04% | -32.66% | -7.99% | -13.88% | -33.92% |
| Gross Profit | -37.64% | 4.57% | 44.13% | 57.96% | 69.67% |
| SG&A Expenses | 0.06% | 3.35% | -4.23% | -10.00% | -11.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.53% | 9.68% | 24.44% | 19.00% | 2.28% |
| Operating Income | -11.89% | -41.22% | -9.52% | 1.39% | 18.11% |
| Income Before Tax | -51.22% | -54.74% | -7.94% | 6.00% | 24.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.22% | -54.74% | -7.94% | 6.00% | 24.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.22% | -54.74% | -7.94% | 6.00% | 24.12% |
| EBIT | -11.89% | -41.22% | -9.52% | 1.39% | 18.11% |
| EBITDA | -12.07% | -42.91% | -9.95% | 1.21% | 18.45% |
| EPS Basic | -44.57% | -39.94% | 5.47% | 20.53% | 33.94% |
| Normalized Basic EPS | -15.22% | -34.01% | 6.20% | 21.20% | 34.57% |
| EPS Diluted | -44.57% | -39.94% | 5.47% | 20.53% | 33.94% |
| Normalized Diluted EPS | -15.22% | -34.01% | 6.20% | 21.20% | 34.57% |
| Average Basic Shares Outstanding | 4.35% | 8.46% | 12.97% | 17.92% | 15.11% |
| Average Diluted Shares Outstanding | 4.35% | 8.46% | 12.97% | 17.92% | 15.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |